Jamison Eaton & Wood’s Bristol-Myers Squibb BMY Stock Holding History

Jamison Eaton & Wood’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$219K	Hold	3,400	–	–	0.06%	108
2014 Q4	$201K	Buy	+3,400	New	+$192K	0.06%	114
2013 Q4	–	Sell	-1,400	Closed	-$65K	–	131
2013 Q3	$65K	Buy	+1,400	New	+$61.5K	0.02%	157

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jamison Eaton & Wood's BMY Position: Q1 2015 in Review

Jamison Eaton & Wood held its Bristol-Myers Squibb (BMY) position steady in Q1 2015 at 3,400 shares worth $219K. The position accounts for 0.06% of the portfolio, ranked #108.

Jamison Eaton & Wood first reported a position in BMY in Q3 2013 and has held it in 3 quarters since. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Jamison Eaton & Wood held 3,400 shares of Bristol-Myers Squibb worth $219K as of Q1 2015.
Jamison Eaton & Wood left its Bristol-Myers Squibb share count unchanged in Q1 2015.
Bristol-Myers Squibb made up 0.06% of Jamison Eaton & Wood's portfolio in Q1 2015, its #108 holding.
Jamison Eaton & Wood first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 3 quarters since.
1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Jamison Eaton & Wood's 13F filing for Q1 2015, filed 30 Apr 2015.